Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
HT-6184 / Halia Therap
NCT06241742: Evaluating Ability of HT-6184 to Reduce Inflammation and Pain After Third Molar Extraction	Completed	2	81	US	HT-6184, HT-6184 Placebo	Halia Therapeutics, Inc.	Pain	04/24	04/24
NCT05447546: Study to Evaluate HT-6184 in Healthy Subjects	Completed	1	64	US	HT-6184, HT-6184 Placebo	Halia Therapeutics, Inc., TKL Research, Inc.	Normal Healthy Subjects	07/23	07/23